pioglitazone has been researched along with Leanness in 4 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of dietary fructose alone or in combination with a new oral agent, pioglitazone, on VLDL-triglyceride (TG) turnover were studied in genetically obese Wistar fatty rats characterized by hyperinsulinemia (7,488 +/- 954 pmol/l), hyperglycemia, (22." | 1.29 | VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone. ( Amano, N; Ebara, T; Hirano, T; Hozumi, T; Ishida, Y; Kazumi, T; Odaka, H; Yoshino, G, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sonta, T | 1 |
| Inoguchi, T | 1 |
| Tsubouchi, H | 1 |
| Sekiguchi, N | 1 |
| Kobayashi, K | 1 |
| Matsumoto, S | 1 |
| Utsumi, H | 1 |
| Nawata, H | 1 |
| Bhat, R | 1 |
| Bhansali, A | 1 |
| Bhadada, S | 1 |
| Sialy, R | 1 |
| Kazumi, T | 1 |
| Hirano, T | 1 |
| Odaka, H | 1 |
| Ebara, T | 1 |
| Amano, N | 1 |
| Hozumi, T | 1 |
| Ishida, Y | 1 |
| Yoshino, G | 1 |
| de Souza, CJ | 1 |
| Eckhardt, M | 1 |
| Gagen, K | 1 |
| Dong, M | 1 |
| Chen, W | 1 |
| Laurent, D | 1 |
| Burkey, BF | 1 |
1 trial available for pioglitazone and Leanness
| Article | Year |
|---|---|
Effect of pioglitazone therapy in lean type 1 diabetes mellitus.
Topics: Blood Glucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hy | 2007 |
3 other studies available for pioglitazone and Leanness
| Article | Year |
|---|---|
Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity.
Topics: Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Electron Spin Resonance Spectrosco | 2004 |
VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone.
Topics: Animals; Body Weight; Cholesterol; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Disease Models, | 1996 |
Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance.
Topics: Adipocytes; Adipose Tissue; Analysis of Variance; Animals; Blood Glucose; Cell Division; Cell Size; | 2001 |